Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LeAnne T Bloedon

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Nutrition Reviews|March 5, 2004
Flaxseed and cardiovascular riskLeAnne T Bloedon, Philippe O Szapary
Current Cardiology Reports|October 16, 2003
Physical activity and its effects on lipidsPhilippe O Szapary, LeAnne T Bloedon, Gary D Foster
Nature Clinical Practice. Cardiovascular Medicine|May 29, 2008
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemiaFrederick F Samaha, James McKenney, Leanne T Bloedon, et al.
Journal of the American College of Nutrition|March 14, 2007
Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse modelsMichael A Pellizzon, Jeffery T Billheimer, Leanne T Bloedon, et al.
Pharmacotherapy|April 16, 2014
Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemiaSony Tuteja, Danielle Duffy, Richard L Dunbar, et al.
Metabolic Syndrome and Related Disorders|May 8, 2009
Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adultsNayyar Iqbal, Serena Cardillo, Sheri Volger, et al.
Journal of Lipid Research|October 26, 2010
Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDLJohn S Millar, Katsunori Ikewaki, LeAnne T Bloedon, et al.
Journal of the American College of Nutrition|May 8, 2008
Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trialLeAnne T Bloedon, Shilpa Balikai, Jesse Chittams, et al.
JAMA|August 14, 2003
Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trialPhilippe O Szapary, Megan L Wolfe, LeAnne T Bloedon, et al.
Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Nutrition Reviews|March 5, 2004
Flaxseed and cardiovascular riskLeAnne T Bloedon, Philippe O Szapary
Current Cardiology Reports|October 16, 2003
Physical activity and its effects on lipidsPhilippe O Szapary, LeAnne T Bloedon, Gary D Foster
Nature Clinical Practice. Cardiovascular Medicine|May 29, 2008
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemiaFrederick F Samaha, James McKenney, Leanne T Bloedon, et al.
Journal of the American College of Nutrition|March 14, 2007
Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse modelsMichael A Pellizzon, Jeffery T Billheimer, Leanne T Bloedon, et al.
Pharmacotherapy|April 16, 2014
Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemiaSony Tuteja, Danielle Duffy, Richard L Dunbar, et al.
Metabolic Syndrome and Related Disorders|May 8, 2009
Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adultsNayyar Iqbal, Serena Cardillo, Sheri Volger, et al.
Journal of Lipid Research|October 26, 2010
Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDLJohn S Millar, Katsunori Ikewaki, LeAnne T Bloedon, et al.
Journal of the American College of Nutrition|May 8, 2008
Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trialLeAnne T Bloedon, Shilpa Balikai, Jesse Chittams, et al.
JAMA|August 14, 2003
Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trialPhilippe O Szapary, Megan L Wolfe, LeAnne T Bloedon, et al.
Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.
Pageof 3